These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 20371173

  • 1. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F, Bai Y, Chen Z, Li Y, Luo L, Huang J, Yang J, Liao H, Guo L.
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differentially expressed microRNAs in small cell lung cancer.
    Miko E, Czimmerer Z, Csánky E, Boros G, Buslig J, Dezso B, Scholtz B.
    Exp Lung Res; 2009 Oct; 35(8):646-64. PubMed ID: 19895320
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H, Huang J, Peng J, Wu X, Zhang Y, Zhu W, Guo L.
    Mol Cancer; 2015 Mar 12; 14():59. PubMed ID: 25880778
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.
    Husted S, Søkilde R, Rask L, Cirera S, Busk PK, Eriksen J, Litman T.
    Mol Pharm; 2011 Dec 05; 8(6):2055-62. PubMed ID: 21899346
    [Abstract] [Full Text] [Related]

  • 9. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, Kroemer G.
    Cancer Res; 2010 Mar 01; 70(5):1793-803. PubMed ID: 20145152
    [Abstract] [Full Text] [Related]

  • 10. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
    Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W, Bai C.
    Oncol Rep; 2010 Jan 01; 23(1):121-8. PubMed ID: 19956872
    [Abstract] [Full Text] [Related]

  • 11. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P.
    Cancer Chemother Pharmacol; 2012 Mar 01; 69(3):723-31. PubMed ID: 21993663
    [Abstract] [Full Text] [Related]

  • 12. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R, Hussey DJ, Haier J.
    Eur J Cancer; 2010 Jan 01; 46(2):298-311. PubMed ID: 19948396
    [Abstract] [Full Text] [Related]

  • 13. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.
    Biomed Pharmacother; 2010 Jul 01; 64(6):399-408. PubMed ID: 20363096
    [Abstract] [Full Text] [Related]

  • 14. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E.
    Cancer Res; 2009 Jul 01; 69(13):5553-9. PubMed ID: 19549910
    [Abstract] [Full Text] [Related]

  • 15. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).
    Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L.
    Exp Lung Res; 2011 Sep 01; 37(7):427-34. PubMed ID: 21787234
    [Abstract] [Full Text] [Related]

  • 16. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
    Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D.
    Ann Surg; 2010 Jun 01; 251(6):1056-63. PubMed ID: 20485139
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 18. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.
    Clin Cancer Res; 2000 May 01; 6(5):2075-86. PubMed ID: 10815935
    [Abstract] [Full Text] [Related]

  • 19. miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1.
    Liu H, Wu X, Huang J, Peng J, Guo L.
    Int J Exp Pathol; 2015 Aug 01; 96(4):240-7. PubMed ID: 26108539
    [Abstract] [Full Text] [Related]

  • 20. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells.
    Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, Jin HO, Park IC, Jin YW, An S.
    Int J Oncol; 2009 Jul 01; 35(1):81-6. PubMed ID: 19513554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.